These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4510913)

  • 21. Mycobacterium malmoense in the north-east of England.
    Connolly MJ; Magee JG; Hendrick DJ; Jenkins PA
    Tubercle; 1985 Sep; 66(3):211-7. PubMed ID: 4049533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H; Takahashi R; Nakai T; Torii R; Yo I
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapeutic activity and diffusion properties of the second series antituberculous preparations].
    Drabkina RO; Ginzburg TS
    Klin Med (Mosk); 1966 Dec; 44(12):38-43. PubMed ID: 4302345
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 25. Activity of certain antibacillary substances in the experimental infection of guinea-pigs exposed to dust by Mycobacterium kansasii.
    Tacquet A; Collet A; Devulder B; Martin JC
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):127-31. PubMed ID: 5632591
    [No Abstract]   [Full Text] [Related]  

  • 26. [Disposition to lung diseases caused by atypical mycobacteria; treatment results and late results].
    Krebs A
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):133-40. PubMed ID: 5632190
    [No Abstract]   [Full Text] [Related]  

  • 27. Mycobacterium kansasii diffuse pulmonary infection in a patient with acquired immune deficiency syndrome. Successful therapy with an antituberculous regimen.
    Jacobson MA; Isenberg WM
    Am J Clin Pathol; 1989 Feb; 91(2):236-8. PubMed ID: 2916466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy of pulmonary Mycobacterium kansasii infection].
    Mizutani S
    Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract]   [Full Text] [Related]  

  • 30. [Isoxyl and T283 in the treatment of photochromogenic infections in mice].
    Burjanová B; Dornetzhuber V
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):123-5. PubMed ID: 5632189
    [No Abstract]   [Full Text] [Related]  

  • 31. [Atypical mycobacterial infections with disseminated localisations].
    Teyssier L; Legrand M; Botto MJ; Lesobre R
    Nouv Presse Med; 1974 Sep; 3(30):1879-82. PubMed ID: 4423406
    [No Abstract]   [Full Text] [Related]  

  • 32. Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.
    Banks J; Jenkins PA; Smith AP
    Tubercle; 1985 Sep; 66(3):197-203. PubMed ID: 4049531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN; Gur'ian IE; Kochetov BI
    Probl Tuberk; 1972; 50(11):21-4. PubMed ID: 4630564
    [No Abstract]   [Full Text] [Related]  

  • 34. Mycobacterium malmoense--problems with treatment and diagnosis--a case report.
    Banks J; Smith AP; Jenkins PA
    Tubercle; 1983 Sep; 64(3):217-9. PubMed ID: 6636306
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary disease caused by Mycobacterium xenopei.
    Doyle WM; Evander LC; Gurft H
    Am Rev Respir Dis; 1968 May; 97(5):919-22. PubMed ID: 5647216
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
    Pulido F; Iribarren JA; Kindelan JM; Moreno S
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mycobacterium fortuitum as a cause of a bilateral tuberculosis-like lung disease associated with a mega-esophagus].
    Dümchen F; Ulber H
    Z Tuberk Erkr Thoraxorg; 1965; 124(5):324-8. PubMed ID: 5899165
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.